Diagnosis and treatment of HER-2-positive breast cancer: Expert consensus of the Chinese Anti-Cancer Association.
- Author:
Ze-Fei JIANG
1
;
Zhi-Min SHAO
;
Bing-He XU
Author Information
1. jiangzefei@medmail.com.cn
- Publication Type:Journal Article
- MeSH:
Antibodies, Monoclonal;
administration & dosage;
Antibodies, Monoclonal, Humanized;
Antineoplastic Combined Chemotherapy Protocols;
therapeutic use;
Breast Neoplasms;
diagnosis;
drug therapy;
metabolism;
pathology;
surgery;
Chemotherapy, Adjuvant;
Cyclophosphamide;
administration & dosage;
Doxorubicin;
administration & dosage;
Female;
Humans;
Neoplasm Recurrence, Local;
Paclitaxel;
administration & dosage;
Receptor, ErbB-2;
metabolism;
Trastuzumab
- From:
Chinese Journal of Oncology
2010;32(2):158-160
- CountryChina
- Language:Chinese
